Jon Tripp

Jon Tripp is the senior director of Communications & Public Affairs for PhRMA. He has over 17 years experience leading online initiatives, media relations and public affairs for non-profit organizations, the federal government and political candidates.

Posts by Jon Tripp

Hospitals

Surprise! Physicians find glitches trying to register for Sunshine Act database

Yesterday, ProPublica released a story, “Error: You Have No Payments from Pharma,” shining a light on some of the problems physicians are facing while trying to register with the online Open Payments/Sunshine system. The article is indicative of many larger issues physicians, teaching hospitals and biopharmaceutical/medical technology companies are facing as they work to register […]

MedCity News eNewsletter

Q&A with John Castellani of PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading biopharmaceutical research and biotechnology companies. Dialogues+ had the opportunity to ask John Castellani, President and CEO of PhRMA, questions about his organization and the Physician Payments Sunshine Act....

presented by
Health IT

A look at life science innovation brought on by physician-biopharm tech hybrids

In this series, Dialogues+ is taking a look at innovation brought about through collaborations between physicians and biopharmaceutical/medical technology companies. Today, we look to potential future innovations and recent developments from the National Institutes of Health. Accelerating Medicines Partnership In February 2014, the National Institutes of Health (NIH) announced a new public-private partnership, the Accelerating […]

BioPharma

P4HD Partners respond to USA Today letter written by John J. Castellani & Jim Greenwood

On February 24, USA Today ran a letter to the editor written by PhRMA President John J. Castellani and Biotechnology Industry Organization President Jim Greenwood responding to an editorial that not only mischaracterized the relationships between physicians and biopharmaceutical and medical technology professionals, but also admonished them. An additional rebuttal by Dr. Thomas Stossel, Professor […]

Devices & Diagnostics

Sunshine online database registration is live for organizations, but what about physicians?

Spread the word: As of February 18th, biopharmaceutical/medical technology organizations and group purchasing organizations (GPOs) can now register and set up their accounts with the Open Payments/Sunshine online database. Biopharmaceutical/medical technology companies are required to register with the database. Registration and data submission will have two phases: Phase 1: This phase will run February 18th […]

Policy

Sunshine Act: CMS explains why textbooks and journals need to be reported

Last October, dozens of professional societies and other organizations, including the American Academy of Family Physicians, American College of Cardiology and the American Medical Association, sent a letter to Secretary Kathleen Sebelius, Secretary of the Department of Health and Human Services, expressing concern over medical journals and textbooks having to be reported under the Sunshine […]